Navigation Links
Mylan Announces Final FDA Approval for Zaleplon Capsules
Date:6/9/2008

PITTSBURGH, June 9 /PRNewswire-FirstCall/ -- Mylan Inc. (NYSE: MYL) today announced that its subsidiary, Genpharm ULC, has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Zaleplon Capsules, 5 mg and 10 mg.

Zaleplon Capsules are the generic version of King Pharmaceuticals' Sonata(R) Capsules, which had U.S. sales of approximately $88 million for the 12 months ending March 31, 2008, according to IMS Health.

This product is shipping immediately and will be sold under the Mylan Pharmaceuticals brand.

Mylan Inc., with a presence in more than 90 countries, ranks among the leading diversified generic and specialty pharmaceutical companies in the world. The company maintains one of the industry's broadest -- and highest quality -- product portfolios, supported by a robust product pipeline; owns a controlling interest in the world's second largest active pharmaceutical ingredient manufacturer; and operates a specialty business focused on respiratory and allergy therapies.


'/>"/>
SOURCE Mylan Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related medicine news :

1. Mylan Inc. Acquires Central Eastern European Generics Businesses of Merck KGaA
2. Mylan Launches Paroxetine Hydrochloride Extended-Release Tablets
3. Mylan Schedules Financial Results Conference Call and Live Webcast for the First Quarter Fiscal 2008
4. Mylan Declares Quarterly Preferred Stock Dividend
5. Mylan Appoints Michael J. Monroe Senior Vice President for Global Public Affairs
6. Mylan Announces Final FDA Approval for Trandolapril Tablets
7. Mylan Announces Final FDA Approval for Felodipine Extended-Release Tablets, USP
8. Mylan Reports Adjusted Diluted Cash EPS of $0.11 for the Quarter
9. Mylan Announces Appointment of Jagdish Dore as CEO and Managing Director of Matrix Laboratories
10. Mylan Revises Timing of Its Financial Results Conference Call for the Quarter and Nine Months Ended Dec. 31, 2007, to 5 p.m. ET
11. Mylan Confirms Its Matrix Design Fentanyl Patch Is Not Included In the Widespread Recall Announced February 12th

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/8/2009)..., HOLLYWOOD, Calif., Nov. 8 /PRNewswire-USNewsw...lebration of Babies luncheon to recognize prominen...ir children and who are role models for March of D...As part of the March of Dimes November Prematurity... guests were urged to join the fight for preemies!...
(Date:11/7/2009)..., WASHINGTON , Nov. 7 /PRNewswire-USNewswire/... today in support of H.R. 3962, the Affordable Hea...the legislation later tonight. Below are the Spea... all know, is an historic moment for our nation an...aders of every party and political philosophy -- a...
(Date:11/7/2009)..., HOUSTON, Nov. 7 Th...nted Lisa James, Director of Health at the Family ...stinguished Service today at its semi-annual polic...Service is the highest honor the AMA House of Dele... http://www.newscom.com/cgi-bin/prnh/20081209/AMA...
(Date:11/7/2009)..., HOUSTON, Nov. 7 Calling this ...iation (AMA), the AMA President J. James Rohack, M...hysicians from all state and medical specialty soc...icy-making meeting, where health system reform wil...m.com/cgi-bin/prnh/20081209/AMALOGO ) ,, "Ove...
(Date:11/7/2009)..., WASHINGTON, Nov. 7 ...aring, antichoice extremists are holding the entir...a. They are demanding that the bill go far beyond ...een incorporated into the original bill. In an ou...on early Saturday afternoon, antichoice Democrats ...
Breaking Medicine News(10 mins):Health News:Hollywood Stars Joined in a Celebration of Babies 2Health News:Hollywood Stars Joined in a Celebration of Babies 3Health News:Pelosi: Health Legislation Founded on Key Principles for a Healthier America: Innovation, Competition and Prevention 2Health News:Pelosi: Health Legislation Founded on Key Principles for a Healthier America: Innovation, Competition and Prevention 3Health News:Pelosi: Health Legislation Founded on Key Principles for a Healthier America: Innovation, Competition and Prevention 4Health News:AMA Honors Family Violence Prevention Expert 2Health News:AMA President Kicks Off AMA Meeting Focused on Health Reform 2
...ge for nicotine, rat study suggests , , MO...peptide receptor in the brain may be one way to qu...dy suggests. , Hypocretin-1, or Orexin A, a short ...he addictive chemical in tobacco, according to res...
...dicines for conditions that haven,t been studied t...ews) -- It,s called "off-label" prescribing, and i...rug to treat a disease or condition that,s differe...ittle evidence that using a drug for an unapproved...
... to treat anemia in patients with cancer are assoc...lood clots, at a similar rate as other treatments ... at the University of Rochester Medical Center. ,...leading causes of illness and death in people with...
... 24, 2008 A new study finds that youth population...dequate healthcare, and thus may fail to benefit f...Pediatric Blood & Cancer , finds that the patients... abnormally shaped red blood cells, affects close ...
...d by the termite Termes panamensis (Snyder), whi...rded, is sufficient to kill a would-be nest invade...l fellows at the Smithsonian Tropical Research Ins... Panama, established by a donation from the Frank ...
...erdam, The Netherlands and Sun City, AZ, USA -- A ...nal of Alzheimer,s Disease (Volume 15:3) suggests...ment Scale Cognitive (ADAS-Cog) may vary and poss...that contribute to variances seen in this assessme...
Other Medicine News:Health News:Molecular Switch in Brain May End Smokers' Cravings 2Health News:Study Calls for Greater Scrutiny of 'Off-Label' Drug Use 2Health News:Study Calls for Greater Scrutiny of 'Off-Label' Drug Use 3Health News:Study Calls for Greater Scrutiny of 'Off-Label' Drug Use 4Health News:Transfusions increase clot risk in hospitalized cancer patients 2Health News:Children with sickle cell disease receiving inadequate care 2Health News:Panamanian termite goes ballistic: Fastest mandible strike in the world 2Health News:Study suggests reliability of cognitive assessment tool varies widely 2
(Date:11/6/2009)...ov. 6 DUSA Pharmaceutica...company that is developing and marketing Levulan(&...ts focused on patients with common skin conditions...ecutive Officer, will present a corporate overview...on Tuesday, November 10, 2009 at 10:00 a.m. ET at ...
(Date:11/6/2009)...v. 6 Watson Pharmaceutic...aceutical company, announced today that Paul Bisar... will provide an overview and update of the Compan...thcare Conference on Wednesday, November 11, 2009 ...entation will be webcast live and can be accessed ...
(Date:11/6/2009)... 6 Repossessions and liquidations ...rd quarter of 2009 declined as compared to similar...gement,s NasTrac Quarterly Index (NQI). The figur... both repossessions and orderly liquidations, also...uction and printing equipment, offering mixed news...
Breaking Medicine Technology:NasTrac Quarterly Index Shows Decline in Trucking and Machine Tool Repossessions in Q3 2009 2NasTrac Quarterly Index Shows Decline in Trucking and Machine Tool Repossessions in Q3 2009 3NasTrac Quarterly Index Shows Decline in Trucking and Machine Tool Repossessions in Q3 2009 4Reduced Radiation Heart Scans Dont Compromise on Quality 48370 1Reduced Radiation Heart Scans Dont Compromise on Quality 48370 2Donor Stem Cell Transplant Best For Acute Myeloid Leukemia 48368 1Donor Stem Cell Transplant Best For Acute Myeloid Leukemia 48368 2Donor Stem Cell Transplant Best For Acute Myeloid Leukemia 48368 3Randall Terry 3A How Tillers Death and office Closing Can Help Propel Pro Life Movement Derail Sotomayor and Overturn Roe 3B Four Key Senators Will B 48366 1Randall Terry 3A How Tillers Death and office Closing Can Help Propel Pro Life Movement Derail Sotomayor and Overturn Roe 3B Four Key Senators Will B 48366 2
...RT opened airways in less than 15 minutes, WILMIN... pivotal efficacy and safety trials, SHINE and SUN...erol fumarate dihydrate),Inhalation Aerosol signif...ted in patients with moderate to very severe Chron...o budesonide and formotorol administered,alone, an...
... 29 Sanofi-aventis,announced today that the U.S. ...(R) (insulin glulisine [rDNA origin] injection) to... older) with diabetes mellitus., The approval of ...ew of,a 26-week, phase III, open-label, active con... lispro, in 572 children and adolescents (4 years,...
Other Medicine Technology:Pivotal Data Showed SYMBICORT(R) Improved Lung Function in Adults with COPD 2Pivotal Data Showed SYMBICORT(R) Improved Lung Function in Adults with COPD 3Pivotal Data Showed SYMBICORT(R) Improved Lung Function in Adults with COPD 4Pivotal Data Showed SYMBICORT(R) Improved Lung Function in Adults with COPD 5Pivotal Data Showed SYMBICORT(R) Improved Lung Function in Adults with COPD 6Pivotal Data Showed SYMBICORT(R) Improved Lung Function in Adults with COPD 7Pivotal Data Showed SYMBICORT(R) Improved Lung Function in Adults with COPD 8FDA Approves Rapid-Acting Insulin Apidra(R) for Treatment of Children with Diabetes 2FDA Approves Rapid-Acting Insulin Apidra(R) for Treatment of Children with Diabetes 3FDA Approves Rapid-Acting Insulin Apidra(R) for Treatment of Children with Diabetes 4FDA Approves Rapid-Acting Insulin Apidra(R) for Treatment of Children with Diabetes 5
Accu-Temp Fixed, 1205C (2200F), 1/2" shaft with fine tip
...e surgeon with an indirect illumination system tha...ized through the laser microscope. Through use of ... surgeon can enhance visualization of interface de...l flap striae and flap alignment. Use of the Lumin...
...ows you access to the most popular features of the...pes, crowding bars, random sequencing, contrast se...character sequencing eliminates memorization. In a...ne and multiple line selection capability. The B-V...
.... The flexible, fully portable Suzanne sleep data ...e in laboratories or in the patients home. Its uni...cord from 10 to 35 channels of physiological data ... attended or unattended sleep studies. The new Nel...
Medicine Products: